Sector portfolio · Accelerator · United States

Y Combinator's Pharma portfolio

Y Combinator has backed 18 Pharma startups in rounds we track, $141M between them, shown by the stage each has reached. The best-funded is 64x Bio.

18startups backed
3stages
$141Mraised between them
Pre-seed and seedbiggest stage

Y Combinator's whole portfolioY Combinator's profile

Segment by segment

Pre-seed and seed

10 startups · $59M raised

  1. ParcelBioParcelBio is a biotechnology startup based in San Francisco, founded in 2023.United States$26M
  2. ToralgenToralgen is a preclinical-stage biopharmaceutical company based in Indianapolis, Indiana, founded in 2017.United States$8.3M
  3. Granza BioGranza Bio is a biotechnology company based in San Francisco, founded in 2024.United States$7.1M
  4. Signatur BiosciencesSignatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for womeUnited States$7.0M
  5. inSomaBioInSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.United States$4.6M
  6. ExcepGenExcepGen is a biotechnology company based in San Francisco, California, founded in 2017.United States$4.0M
  7. Junction BioscienceJunction Bioscience is a pharmaceutical firm that is developing an autonomous AI scientist to guide the discovery of breakthrough drugs.United States$500K
  8. Cisterna BiologicsCisterna Biologics is a biotechnology company based in Carlsbad, California, founded in 2022.United States$500K

Stage not reported

6 startups · $27M raised

  1. Forum MarketsForum Markets developing novel drugs for treating distinct inflammatory diseases.United States$10M
  2. Andson BiotechAndson Biotech is a biotechnology company based in Atlanta, Georgia, focused on developing innovative biotools to enhance mass speUnited States$8.3M
  3. SeedSeed is a mobile banking service designed for freelancers, startups, and small businesses.United States$6.0M
  4. Epigene LabsEpigene Labs is a biotechnology company founded in 2019, focused on enhancing precision oncology research and drug development.France$1.6M
  5. FBFelix BiotechnologyFelix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.United States$314K
  6. SynviviaSynvivia creates organisms that can be controlled with small molecules.United States$256K

Series A

2 startups · $55M raised

  1. 64x Bio64x Bio is a biotechnology company founded in 2017-2018 as a spinout from Harvard University’s Wyss Institute and George Church’s lab.United States$55M
  2. Intact TherapeuticsIntact Therapeutics is a clinical-stage biopharmaceutical company founded in 2015, specializing in next-generation localized drug United States$250K

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Y Combinator as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Y Combinator?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.